Betty Wang, MD, recaps 3 key urologic cancer studies from EAU 2025
Betty Wang, MD, provides insight on 3 presentations that she believes “may be game changing” in urology.
Lower-dose abiraterone offers viable alternative to standard-dose for mCRPC
Long-term data support radium-223 safety in mCRPC
Survey: New NMIBC treatments face slow uptake
RCT compares platinum/5-FU, platinum/paclitaxel in high-risk penile cancer